Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

ClinicalTrials.gov ID: NCT06553027

Public ClinicalTrials.gov record NCT06553027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Complications

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.

Study identification

NCT ID
NCT06553027
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cerevance
Industry
Enrollment
330 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 20, 2024 (Actual)
Primary completion
Aug 2026 (Estimated)
Completion
Aug 2026 (Estimated)
Last update posted
Apr 17, 2026

2024 – 2026

United States locations

U.S. sites
53
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
The Kirklin Clinic of UAB Hospital Birmingham Alabama 35233 —
University of Alabama at Birmingham Birmingham Alabama 35233 —
University of Alabama at Birmingham ALS Clinic Birmingham Alabama 35294 —
Barrow Neurological Institute Phoenix Arizona 85013 —
Muhammad Ali Parkinson Center Phoenix Arizona 85013 —
St. Joseph's Hospital and Medical Center Phoenix Arizona 85013 —
Parkinson's Research Centers of America - Orange county Aliso Viejo California 92656 —
Parkinson's Research Centers of America - Orange County Newport Beach California 92663 —
Parkinson's Research Centers of America - Palo Alto Palo Alto California 94301 —
CenExel Rocky Mountain Clinical Research Englewood Colorado 80113 —
David and Rhoda Chase Family Movement Disorders Center - Vernon Vernon Connecticut 06066 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
SFM Clinical Research, LLC Boca Raton Florida 33487 —
K2 Medical Research Maitland Florida 32751 —
Renstar Medical Research Ocala Florida 34471 —
N1 Research LLc Orlando Florida 32825 —
Parkinson's Disease Center of SWFL Port Charlotte Florida 33980 —
University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - Brain & Spine Institute Port Orange Florida 32127 —
USF Parkinson's Disease and Movement Disorders Center Tampa Florida 33613 —
Atlanta Neuroscience Institute Atlanta Georgia 30327 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Kentucky, Dept of Neurology Kentucky Neuroscience Institute Research Lexington Kentucky 40536 —
Boston Clinical Trials Boston Massachusetts 02131 —
University of Michigan Dept. of Neurology Ann Arbor Michigan 48109 —
University of Michigan Hospital - Michigan Clinical Research Unit (MCRU) Ann Arbor Michigan 48109 —
Quest Research Institute Farmington Hills Michigan 48334 —
Boro Neurology Hopewell New Jersey 08525 —
Global Neurosciences Institute at Pennington Pennington New Jersey 08534 —
Parkinson's Research Centers of America - Long Island Commack New York 11725 —
Weill Cornell Medical College New York New York 10021 —
The Neurological Institute Charlotte North Carolina 28204 —
Duke Neurology Morreene Road Clinic Durham North Carolina 27705 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Velocity Clinical Research Raleigh North Carolina 27607 —
Riverhills Healthcare, Inc dba Riverhills Neuroscience Cincinnati Ohio 45212 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
The Ohio State University - Martha Morehouse Medical Plaza Columbus Ohio 43221 —
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136 —
Oregon Health and Science University Portland Oregon 97239 —
Medical University of South Carolina Charleston South Carolina 29425 —
Veracity Neuroscience LLC Memphis Tennessee 38157 —
Horizon Clinical Research Group Cypress Texas 77429 —
Texas Movement Disorder Specialists, PLLC Georgetown Texas 78628 —
Houston Methodist Neurological Institute Houston Texas 77030 —
Gill Neuroscience Houston Texas 77065 —
Central Texas Neurology Consultants Round Rock Texas 78681 —
Inova Parkinson's and Movement Disorders Center - Alexandria Alexandria Virginia 22311 —
Inova Neurology - Fairfax Fairfax Virginia 22031 —
Inova Fairfax Medical Campus Falls Church Virginia 22042 —
Henrico Doctors Neurology Associates, LLC Richmond Virginia 23229 —
EvergreenHealth Research Department Kirkland Washington 98034 —
Inland Northwest Research Spokane Washington 99202 —
Medical College of Wisconsin-Department of Neurology Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06553027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06553027 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →